November 2, 2020 — Hologic, Inc. announced the commercial availability in Europe of its 3DQuorum Imaging Technology, Powered by Genius AI.

November 2, 2020 — Focusing ultrasound energy on a target site in the body to generate heat can burn and destroy the tissue in the site without a surgical procedure. This method is clinically applied to treat uterine fibroids, prostatic hyperplasia, prostate cancer, metastatic bone tumor and other types of tumor to destroy tumor cells using heat. However, there is a potential problem that the surrounding tissue may be burned in the process due to heat diffusion.

November 2, 2020 — Bladder preservation with trimodality therapy can be a safe and effective alternative to cystectomy for selected patients with muscle-invasive bladder cancer. The phase II NRG Oncology NRG-RTOG 0712 trial evaluated two regimens.

November 2, 2020 — Though Black women get breast cancer at a 3% lower incidence rate than white women, they are 42% more likely to die of breast cancer than white women. Wait a minute! That doesn’t make sense. Isn’t the death rate from breast cancer on a downward trend?

October 30, 2020 — Researchers involved in the phase II NRG Oncology RTOG 0526 trial studying low dose rate (LDR) prostate brachytherapy (BT) following local recurrence (LR) after external beam radiotherapy (

October 30, 2020 — Computed tomography angiogram (CTA) scans may offer fast and early detection of COVID-19 in acute ischemic stroke (AIS) patients, according to

October 30, 2020 — A team of researchers in Madrid, Spain, and another team in Toronto, Canada, are the first in the world to use focused ultrasound technology to target a new area of the brain in patients with Parkinson's disease and potentially curb, or even reverse, its progression.

October 29, 2020 — Accuray Incorporated, a pioneer in the robotic stereotactic radiosurgery (SRS) field announced a collaboration with Brainlab, a Munich, Germany based market leader in digital surgery and precision radiotherapy that will enhance and expand the Accuray CyberKnife treatmen

October 29, 2020 — medQ Incannounced that they will be participating in the RSNA 2020 annual meeting sta

October 29. 2020 — DiA Imaging Analysis announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the commercial use of LVivo Seamless for automatic view selection. LVivo Seamless algorithms automatically run "behind the scenes" to select the optimal cardiac ultrasound views out of 40-60 views in standard echocardiogram exams.

Subscribe Now